Journal
CURRENT HIV RESEARCH
Volume 10, Issue 1, Pages 27-35Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157016212799304643
Keywords
Microbicide; HIV; reverse transcriptase; NtRTI; NNRTI; NRTI; gel; intravaginal ring
Categories
Funding
- European Commission
Ask authors/readers for more resources
The CAPRISA 004 study in South Africa has accelerated the development of vaginal and rectal microbicides containing antiretrovirals that target specific enzymes in the reproduction cycle of HIV, especially reverse transcriptase inhibitors (RTI). In this review we discuss the potential relevance of HIV-1 RTIs as microbicides, focusing in the nucleotide RTI tenofovir and six classes of nonnucleoside RTIs (including dapivirine, UC781, urea and thiourea PETTs, DABOs and a pyrimidinedione). Although tenofovir and dapivirine appear to be most advanced in clinical trials as potential microbicides, several issues remain unresolved, e. g., the importance of nonhuman primates as a gatekeeper for clinical trials, the emergence and spread of drug-resistant mutants, the combination of microbicides that target different phases of viral reproduction and the accessibility to microbicides in low-income countries. Thus, here we discuss the latest research on RTI as microbicides in the light of the continuing spread of the HIV pandemic from the point of view of medicinal chemistry, virological, and pharmaceutical studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available